Prostate cancer- is marked by an uncontrolled (malignant) growth of cells in the

prostate gland. The prostate is the walnut-sized gland in men, located just below the
bladder and in front of the rectum, surrounding the urethra.

Prostate Cancer is the most common cancer in men other than nonmelanoma
skin cancer. It is the second most common cause of cancer death in men, exceeded
only by lung cancer, and is responsible for 10% of cancer-related deaths in men
older than 55 years of age.

Incidence, Mortality and Survival

The incidence rate starts rising sharply at age 55 years and continues to rise
with increasing age. The incidence rate had increased from 1980 to 2007, with an
annual change of 2.1%.

Figure shows that the highest incidence rates in 2003-2007 were observed in
the cities of San Juan, Mandaluyong and Las Piñas (40-52), and the lowest incidence
were in Rizal province (19.4).

Figure 28. Metro Manila and Rizal Province age-standardized incidence

rates, Prostate cancer, males, 2003-2007.

In 2012, the estimated age-standardized national incidence rate was 18 per

100,000. Two (1.8) out of 100 males would have had a likelihood of getting prostate
cancer before age 75. The estimated national standardized mortality rate was 11.3
per 100,000. One (1.1) out of 100 males would have died from prostate cancer
before age 75.
 In 2015, cancer of the prostate will be the 6th most common in both sexes (5%),
and 3rd among males (7%). There will be 5,526 new cases. There will be 2,912
deaths.

Figure 29 shows that in 2012 the incidence rates were extremely high in the United
States, Europe and Israel, where widespread PSA testing had partly contributed to
the increasing incidence, and a very low incidence/mortality ratio. The
incidence/mortality ratio was also high in Korea, Japan, and Singapore and lower in
the Philippines, China, Thailand and
Malaysia.

In the Philippines, a report described a median survival of 52 months, a 43% 5-year

survival rate and a 31% 10-year survival rate.